Your browser doesn't support javascript.
loading
Cytosolic 5'-nucleotidase 1A autoantibody profile and clinical characteristics in inclusion body myositis.
Lilleker, J B; Rietveld, A; Pye, S R; Mariampillai, K; Benveniste, O; Peeters, M T J; Miller, J A L; Hanna, M G; Machado, P M; Parton, M J; Gheorghe, K R; Badrising, U A; Lundberg, I E; Sacconi, S; Herbert, M K; McHugh, N J; Lecky, B R F; Brierley, C; Hilton-Jones, D; Lamb, J A; Roberts, M E; Cooper, R G; Saris, C G J; Pruijn, G J M; Chinoy, H; van Engelen, B G M.
Afiliación
  • Lilleker JB; Centre for Musculoskeletal Research, Division of Musculoskeletal and Dermatological Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, The University of Manchester, Manchester, UK.
  • Rietveld A; Greater Manchester Neurosciences Centre, Salford Royal NHS Foundation Trust, Stott Lane, Salford, UK.
  • Pye SR; Department of Neurology, Center for Neuroscience Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Mariampillai K; Centre for Musculoskeletal Research, Division of Musculoskeletal and Dermatological Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, The University of Manchester, Manchester, UK.
  • Benveniste O; Department of Internal Medicine and Clinical Immunology, La Pitié-Salpêtrière Hospital, AP-HP, INSERM U974, UPMC, Paris, France.
  • Peeters MT; Department of Internal Medicine and Clinical Immunology, La Pitié-Salpêtrière Hospital, AP-HP, INSERM U974, UPMC, Paris, France.
  • Miller JA; Department of Neurology, Center for Neuroscience Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Hanna MG; Department of Neurology, Royal Victoria Hospitals, The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle, UK.
  • Machado PM; MRC Centre for Neuromuscular Diseases, Institute of Neurology, University College London, London, UK.
  • Parton MJ; MRC Centre for Neuromuscular Diseases, Institute of Neurology, University College London, London, UK.
  • Gheorghe KR; Centre for Rheumatology Research, University College London, London, UK.
  • Badrising UA; MRC Centre for Neuromuscular Diseases, Institute of Neurology, University College London, London, UK.
  • Lundberg IE; Unit of Rheumatology, Department of Medicine, Karolinska University Hospital, Solna, Karolinska Institutet, Stockholm, Sweden.
  • Sacconi S; Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands.
  • Herbert MK; Unit of Rheumatology, Department of Medicine, Karolinska University Hospital, Solna, Karolinska Institutet, Stockholm, Sweden.
  • McHugh NJ; Peripheral Nervous System, Muscle and ALS Department, Université Côté Azure (UCA), Nice University Hospital, Nice, France.
  • Lecky BR; Department of Biomolecular Chemistry, Radboud Institute for Molecular Life Sciences and Institute for Molecules and Materials, Radboud University, Nijmegen, The Netherlands.
  • Brierley C; Royal National Hospital for Rheumatic Diseases and Department of Pharmacy and Pharmacology, University of Bath, Bath, UK.
  • Hilton-Jones D; The Walton Centre NHS Foundation Trust, Fazakerley, Liverpool, UK.
  • Lamb JA; Department of Neurology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
  • Roberts ME; Nuffield Department of Clinical Neurosciences, Oxford University Hospitals, Oxford, UK.
  • Cooper RG; Centre for Integrated Genomic Medical Research, University of Manchester, Manchester, UK.
  • Saris CG; Greater Manchester Neurosciences Centre, Salford Royal NHS Foundation Trust, Stott Lane, Salford, UK.
  • Pruijn GJ; Centre for Integrated Genomic Medical Research, University of Manchester, Manchester, UK.
  • Chinoy H; MRC-ARUK Institute for Ageing and Chronic Disease, University of Liverpool, Liverpool, UK.
  • van Engelen BG; Rheumatology Department, Salford Royal NHS Foundation Trust, Salford, UK.
Ann Rheum Dis ; 76(5): 862-868, 2017 May.
Article en En | MEDLINE | ID: mdl-28122761
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Autoanticuerpos / 5'-Nucleotidasa / Fibras Musculares Esqueléticas / Miositis por Cuerpos de Inclusión Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Rheum Dis Año: 2017 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Autoanticuerpos / 5'-Nucleotidasa / Fibras Musculares Esqueléticas / Miositis por Cuerpos de Inclusión Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Rheum Dis Año: 2017 Tipo del documento: Article País de afiliación: Reino Unido